Safety, tolerability, and risks associated with first- and second-generation antipsychotics: a state-of-the-art clinical review-Reference-Cited by-同舟云学术

Safety, tolerability, and risks associated with first- and second-generation antipsychotics: a state-of-the-art clinical review

Published:2017-06 Issue: Volume:Volume 13 Page:757-777
ISSN:1178-203X
Container-title:Therapeutics and Clinical Risk Management
language:en
Short-container-title:TCRM

Author:

Solmi Marco^ORCID,Murru Andrea,Pacchiarotti Isabella,Undurraga Juan^ORCID,Veronese Nicola,Fornaro Michele^ORCID,Stubbs Brendon,Monaco Francesco,Vieta Eduard^ORCID,Seeman Mary^ORCID,Correll Christoph,Carvalho André^ORCID

Publisher

Informa UK Limited

Subject

Chemical Health and Safety,Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,Safety Research,General Medicine

Cited by 316 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Advances in representative small-molecule DRD2 inhibitors: Synthetic Routes and clinical applications;European Journal of Medicinal Chemistry;2024-11

2. Risk factors, prevention and treatment of weight gain associated with the use of antidepressants and antipsychotics: a state-of-the-art clinical review;Expert Opinion on Drug Safety;2024-09-03

3. Optimisation of pharmacotherapy in psychiatry through therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests: Focus on antipsychotics;The World Journal of Biological Psychiatry;2024-09

4. Treatment of Cognitive Impairment Associated with Schizophrenia Spectrum Disorders: New Evidence, Challenges, and Future Perspectives;Brain Sciences;2024-08-06

5. Impact of quetiapine on ion channels and contractile dynamics in rat ventricular myocyte;European Journal of Pharmacology;2024-08